Newsmeme!
Discover News you didn't know existed
The holiday season is usually a time of joy but it also brings the potential for poisonings, according to the Drug and Poison Information Center (DPIC), a service of Cincinnati Children's Hospital Medical Center. The following information includes safety hazards and precautionary ways to ensure that families have a safe holiday season.
NanoVector, Inc. announced today that it has licensed the plant virus nanoparticle drug delivery system developed by Professors' Stefan Franzen and Steven Lommel from North Carolina State University.
Research and Markets ( http://www.researchandmarkets.com/research/247552/pathway_analysis_f ) has announced the addition of John Wiley and Sons Ltd's new report " Pathway Analysis for Drug Discovery: Computational Infrastructure and Applications " to their offering.
( WeissComm Partners ) Horizon Therapeutics, Inc., a privately held biopharmaceutical company, today announced that two pivotal Phase 3 trials evaluating its lead investigational product candidate, HZT 501, met all primary endpoints. HZT 501, a novel, proprietary fixed-dose combination product containing ibuprofen and famotidine, demonstrated a statistically significant reduction in the ...
DUBLIN, Ireland----Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Pathway Analysis for Drug Discovery: Computational Infrastructure and Applications" to their offering.
NEW YORK----Reportlinker.com announces that a new market research report related to the Biotechnologies and Genetics industry is available in its catalogue.
Two cases of liver toxicity caused by the anti-HIV drug abacavir ( Ziagen , also in the combination pill Kivexa ) have been reported in the November 30 th edition of AIDS . Both cases involved young women who changed their HIV treatment to include abacavir.
NanoVector, Inc. announced today that it has licensed the plant virus nanoparticle drug delivery system developed by Professors’ Stefan Franzen and Steven Lommel from North Carolina State University. “This is breakaway technology that will finally provide the highly sought after selective targeting of tumors and intracellular delivery of anti-cancer agents for improved efficacy and fewer ...
Horizon Therapeutics, Inc., a privately held biopharmaceutical company, today announced that two pivotal Phase 3 trials evaluating its lead investigational product candidate, HZT-501, met all primary endpoints.
MORRIS PLAINS, N.J., Dec. 2, 2008 -- Immunomedics, Inc. , a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that seven presentations involving its potential products will be given at the 50th American Society of Hematology Annual Meeting, scheduled for December 6 - 9, 2008, in San Francisco, California.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |